Mono, dual and triple moxifloxacin-based therapies for Helicobacter pylori eradication

Simona Di Caro; Veronica Ojetti; Maria Assunta Zocco; Filippo Cremonini; F Bartolozzi; Marcello Candelli; Andrea Lupascu; Ec Nista; Giovanni Cammarota; Antonio Gasbarrini

Mono, dual and triple moxifloxacin-based therapies for Helicobacter pylori eradication

Simona Di Caro
, Veronica Ojetti
, Maria Assunta Zocco
, Filippo Cremonini
, F Bartolozzi
, Marcello Candelli
, Andrea Lupascu
, Ec Nista
, Giovanni Cammarota
, Antonio Gasbarrini

Risultato della ricerca: Contributo in rivista › Articolo

Abstract

Moxifloxacin is a broad spectrum fluoroquinolone with single daily administration, currently used, above all, for respiratory tract infections.

Lingua originale	Inglese
pagine (da-a)	527-532
Numero di pagine	6
Rivista	ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume	16
Stato di pubblicazione	Pubblicato - 2002

Keywords

2-Pyridinylmethylsulfinylbenzimidazoles
Anti-Bacterial Agents
Aza Compounds
Clarithromycin
Drug Combinations
Fluoroquinolones
Helicobacter Infections
Helicobacter pylori
Omeprazole
Patient Compliance
Quinolines
Treatment Outcome

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{7a1d28cf0fbb46c9863e77ad3a2ee7b8,

title = "Mono, dual and triple moxifloxacin-based therapies for Helicobacter pylori eradication",

abstract = "Moxifloxacin is a broad spectrum fluoroquinolone with single daily administration, currently used, above all, for respiratory tract infections.",

keywords = "2-Pyridinylmethylsulfinylbenzimidazoles, Anti-Bacterial Agents, Aza Compounds, Clarithromycin, Drug Combinations, Fluoroquinolones, Helicobacter Infections, Helicobacter pylori, Omeprazole, Patient Compliance, Quinolines, Treatment Outcome, 2-Pyridinylmethylsulfinylbenzimidazoles, Anti-Bacterial Agents, Aza Compounds, Clarithromycin, Drug Combinations, Fluoroquinolones, Helicobacter Infections, Helicobacter pylori, Omeprazole, Patient Compliance, Quinolines, Treatment Outcome",

author = "\{Di Caro\}, Simona and Veronica Ojetti and Zocco, \{Maria Assunta\} and Filippo Cremonini and F Bartolozzi and Marcello Candelli and Andrea Lupascu and Ec Nista and Giovanni Cammarota and Antonio Gasbarrini",

year = "2002",

language = "English",

volume = "16",

pages = "527--532",

journal = "ALIMENTARY PHARMACOLOGY \& THERAPEUTICS",

issn = "0269-2813",

publisher = "Blackwell Science Limited:PO Box 88, Oxford OX2 0NE United Kingdom:011 44 1865 776868, 011 44 1865 206038, EMAIL: [email protected], INTERNET: http://www.blackwell-science.com, Fax: 011 44 1865 721205",

}

TY - JOUR

T1 - Mono, dual and triple moxifloxacin-based therapies for Helicobacter pylori eradication

AU - Di Caro, Simona

AU - Ojetti, Veronica

AU - Zocco, Maria Assunta

AU - Cremonini, Filippo

AU - Bartolozzi, F

AU - Candelli, Marcello

AU - Lupascu, Andrea

AU - Nista, Ec

AU - Cammarota, Giovanni

AU - Gasbarrini, Antonio

PY - 2002

Y1 - 2002

N2 - Moxifloxacin is a broad spectrum fluoroquinolone with single daily administration, currently used, above all, for respiratory tract infections.

AB - Moxifloxacin is a broad spectrum fluoroquinolone with single daily administration, currently used, above all, for respiratory tract infections.

KW - 2-Pyridinylmethylsulfinylbenzimidazoles

KW - Anti-Bacterial Agents

KW - Aza Compounds

KW - Clarithromycin

KW - Drug Combinations

KW - Fluoroquinolones

KW - Helicobacter Infections

KW - Helicobacter pylori

KW - Omeprazole

KW - Patient Compliance

KW - Quinolines

KW - Treatment Outcome

KW - 2-Pyridinylmethylsulfinylbenzimidazoles

KW - Anti-Bacterial Agents

KW - Aza Compounds

KW - Clarithromycin

KW - Drug Combinations

KW - Fluoroquinolones

KW - Helicobacter Infections

KW - Helicobacter pylori

KW - Omeprazole

KW - Patient Compliance

KW - Quinolines

KW - Treatment Outcome

UR - http://hdl.handle.net/10807/20787

M3 - Article

SN - 0269-2813

VL - 16

SP - 527

EP - 532

JO - ALIMENTARY PHARMACOLOGY & THERAPEUTICS

JF - ALIMENTARY PHARMACOLOGY & THERAPEUTICS

ER -

Mono, dual and triple moxifloxacin-based therapies for Helicobacter pylori eradication

Abstract

Keywords

Altri file e collegamenti

Fingerprint

Cita questo